The global empty iv bag market was valued at USD 2.85 billion in 2025. The market is projected to grow from USD 3.04 billion in 2026 to USD 5.37 billion by 2034, exhibiting a compound annual growth rate of 7.37% during the forecast period. Contrive Datum Insights presents this information in its report titled "Empty Iv Bag Market Size, Share & Industry Analysis, By Type (PVC Empty IV Bags, Non-PVC Empty IV Bags), Application (Hospital, Clinic), Chamber type (Single Chamber, Multi-chamber), Capacity (251-1000 mL, Above 1000 mL, Up to 250 mL), Distribution channel (Direct/Institutional Tenders, Retail Pharmacy & Distributors), and Regional Forecast, 2026-2034".
An empty IV bag is a flexible plastic container, made from PVC or non-PVC polymer film, sold unfilled for later fill-finish with intravenous fluids, injectable medications, or parenteral nutrition solutions. Buyers are pharmaceutical manufacturers, contract fill-finish operators, compounding pharmacies, and hospitals and clinics that prepare or receive sterile fluid products. Bags vary by chamber configuration, fill volume, and film material to suit different clinical delivery and drug-compatibility needs.
Rising volume of inpatient and surgical procedures requiring intravenous fluid delivery
Rising volume of inpatient and surgical procedures requiring intravenous fluid delivery is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.37% a year, the type lines exposed to it move fastest: Non-PVC Empty IV Bags compounds at 9.81%, taking its share of revenue from 38.9% to 48% and its value from USD 1.11 billion to USD 2.58 billion.
The study also runs a bull case: the bull case assumes faster regulatory-driven substitution toward non-PVC film and a quicker build-out of outpatient and homecare infusion capacity in Asia Pacific and Latin America than the base case expects. That path ends 2034 at USD 6.01 billion, above the USD 5.37 billion base case.
Against that, the bear case assumes slower material substitution and tighter hospital capital budgets that delay the transition to non-PVC and multi-chamber bag formats. On that reading 2034 revenue stops at USD 4.83 billion. The weight of the problem sits in PVC Empty IV Bags: 61.1% of 2025 revenue growing at 5.48%, well under the market's 7.37%.
PVC Empty IV Bags Scale Against Non-PVC Empty IV Bags Momentum
The type axis, not the regional one, is what divides the field. PVC Empty IV Bags is the volume position, 61.1% of 2025 revenue at USD 1.74 billion, holding 52% through 2034, and it is defended by scale. Non-PVC Empty IV Bags is the growth position at 9.81%, and it is open. Strength in one does not carry into the other.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Type | PVC Empty IV Bags | 61.1% · USD 1.74 billion | — |
| Application | Hospital | 77.9% · USD 2.22 billion | Clinic 9.28% |
| Chamber type | Single Chamber | 70.2% · USD 2 billion | Multi-chamber 9.54% |
| Capacity | 251-1000 mL | 57.9% · USD 1.65 billion | Above 1000 mL 9.19% |
| Distribution channel | Direct/Institutional Tenders | 82.1% · USD 2.34 billion | Retail Pharmacy & Distributors 9.77% |
- Regionally, the lead sits with North America: 34% of 2025 global revenue, USD 0.97 billion rising to USD 1.66 billion in 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 28% in 2025 to 32% in 2034, with revenue growing from USD 0.8 billion to USD 1.72 billion.
- At 5% of 2025 revenue and 5.5% by 2034, Middle East and Africa is the smallest region throughout.
- The fastest type line is Non-PVC Empty IV Bags, forecast to compound at 9.81% through the period.
- The United States is the largest single country market at USD 0.82 billion in 2025, 28.8% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by type, and by application, chamber type, capacity and distribution channel. The headline total carries bear, base and bull cases at USD 4.83 billion and USD 6.01 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.